hccpjournal.com/about
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
Hereditary Cancer in Clinical Practice
official impact factor 1.68
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My Hereditary Cancer in Clinical Practice

Submit a manuscript Register Sign up for article alerts Contact us Follow
BioMed Central
Support

Search information pages

Advertisement
  • General information
  • Editorial Board
  • FAQ
  • Contact us
  • Privacy policy

Prof Rolf Sijmons


photo
  • University Medical Center Groningen
  • Netherlands
  • Find publications in PubMed

Rolf Sijmons has worked as a clinical geneticist in the field of oncogenetics for more than 20 years. He is Consultant in Clinical Oncogenetics and Professor of Medical Translational Genetics at the University Medical Center Groningen, the Netherlands. His research interests mainly focus on the genetics of colorectal cancer, the clinical interpretation of unclassified variants, bioinformatics tools to support clinical management of cancer families and clinical applications of nextgen sequencing technology. He is member of several international committees in these fields and is editor of the familial cancer database.

A family history of cancer is a powerful indicator of cancer risk. Many hundreds of familial cancer syndromes with high penetrant mutations exist. In addition, combinations of low-penetrant germline mutations may add up to significant cancer risks in individuals. The practical aspects of recognizing familial cancer syndromes, studying the inherited causes of cancer and researching the medical management of patients and families with high genetic risks are the topics of our journal. Publishing in an open access format supports the spread of knowledge on hereditary cancer within the professional community.

A family history of cancer is a powerful indicator of cancer risk. Many hundreds of familial cancer syndromes with high penetrant mutations exist. In addition, combinations of low-penetrant germline mutations may add up to significant cancer risks in individuals. The practical aspects of recognizing familial cancer syndromes, studying the inherited causes of cancer and researching the medical management of patients and families with high genetic risks are the topics of our journal. Publishing in an open access format supports the spread of knowledge on hereditary cancer within the professional community.


  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.